Aug 6, 2026 07:00AM
Jul 28, 2026 07:00AM
Jul 28, 2026 07:00AM
May 19, 2026 07:01AM
May 19, 2026 07:00AM
May 18, 2026 08:34AM
May 7, 2026 07:00AM Cullinan Therapeutics Provides Corporate Update and Reports First Quarter 2026 Financial Results
Apr 28, 2026 07:00AM
Apr 28, 2026 07:00AM
Mar 10, 2026 07:00AM
Jan 8, 2026 07:05AM
Jan 8, 2026 07:00AM
Dec 8, 2025 10:34AM
Dec 8, 2025 10:31AM Cullinan Therapeutics Showcases Compelling Clinical Data in AML for CLN-049, Novel FLT3xCD3 T Cell Engager, in Oral Presentation at the 67th ASH Meeting
Dec 1, 2025 07:00AM
Dec 1, 2025 07:00AM
Nov 21, 2025 06:40AM
Nov 20, 2025 07:13AM
Nov 20, 2025 07:00AM
Nov 6, 2025 07:00AM
Oct 12, 2025 06:27PM Taiho Oncology and Cullinan Therapeutics Present Data on Zipalertinib in Patients with NSCLC with EGFR mutations and Active Brain Metastases at the ESMO Congress 2025
Sep 9, 2025 05:30AM
Aug 21, 2025 06:35AM
Aug 7, 2025 07:00AM
Jul 22, 2025 07:01AM
Jul 22, 2025 07:00AM
Jun 1, 2025 08:21AM
May 22, 2025 05:15PM Cullinan Therapeutics, Taiho Pharmaceutical, and Taiho Oncology to Present Positive Results from Pivotal Phase 2b REZILIENT1 Trial of Zipalertinib at ASCO 2025
May 8, 2025 07:00AM
Apr 29, 2025 07:03AM
Apr 29, 2025 07:00AM
Apr 23, 2025 10:14AM
Apr 16, 2025 07:00AM
Apr 16, 2025 07:00AM
Feb 27, 2025 07:00AM Cullinan Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full Year 2024 Financial Results
Jan 30, 2025 06:39AM
Jan 28, 2025 07:00PM
Nov 7, 2024 07:00AM
Oct 17, 2024 06:54AM
Oct 16, 2024 07:00AM
Oct 16, 2024 07:00AM
Sep 18, 2024 06:40AM H.C. Wainwright Reiterates Buy Rating on Cullinan Oncology Inc. (CGEM)
Sep 18, 2024 06:20AM
Sep 17, 2024 07:00AM
Sep 17, 2024 07:00AM
Sep 16, 2024 07:08AM
Sep 16, 2024 07:02AM
Sep 16, 2024 07:00AM
Sep 14, 2024 04:15AM Cullinan Therapeutics Presents Positive Updated Data from Module C of Zipalertinib Pivotal Phase 2b Study at ESMO 2024
Aug 8, 2024 07:00AM

327,804 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All